Invited speakers
The following invited speakers have confirmed their participation:
Thomas Lengauer (Max Planck Institute for Informatics, Saarbrücken, Germany) - Genotpyic basis of viral tropism
Mike Farzan (Harvard University, Cambridge, USA) - Targeting the co-receptor binding region of HIV-1 gp120
Yves Levy (Hospital Bichat-Claude Bernard, Paris, France) - Potential immunological benefits of CCR5 antagonists
Mike Westby (Pfizer Global Research and Development) - Determination of genotypic barriers entry inhibitors
Brandon Keele (University of Alabamy) - Viral tropism, transmission and diversity
Thomas Lengauer (Max Planck Institute for Informatics, Saarbrücken, Germany) - Genotpyic basis of viral tropism
Mike Farzan (Harvard University, Cambridge, USA) - Targeting the co-receptor binding region of HIV-1 gp120
Yves Levy (Hospital Bichat-Claude Bernard, Paris, France) - Potential immunological benefits of CCR5 antagonists
Mike Westby (Pfizer Global Research and Development) - Determination of genotypic barriers entry inhibitors
Brandon Keele (University of Alabamy) - Viral tropism, transmission and diversity